NIH mouse study finds gut microorganisms may determine cancer treatment outcome
An intact population of microorganisms that derive food and benefit from other organisms living in the intestine is required for optimal response to cancer therapy, according to a mouse study by scientists at the National Cancer Institute (NCI), part of the National Institutes of Health, and their collaborators.
This page was last updated on Friday, January 21, 2022